Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice

Abstract Increased expression of Interleukin (IL)-33 has been detected in intestinal samples of patients with ulcerative colitis, a condition associated with increased risk for colon cancer, but its role in the development of colorectal cancer has yet to be fully examined. Here, we investigated the...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zhengxiang He, Lili Chen, Fabricio O. Souto, Claudia Canasto-Chibuque, Gerold Bongers, Madhura Deshpande, Noam Harpaz, Huaibin M. Ko, Kevin Kelley, Glaucia C. Furtado, Sergio A. Lira
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/88385b01bc9042b29b43f9645a0ed849
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:88385b01bc9042b29b43f9645a0ed849
record_format dspace
spelling oai:doaj.org-article:88385b01bc9042b29b43f9645a0ed8492021-12-02T16:06:39ZEpithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice10.1038/s41598-017-05716-z2045-2322https://doaj.org/article/88385b01bc9042b29b43f9645a0ed8492017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-05716-zhttps://doaj.org/toc/2045-2322Abstract Increased expression of Interleukin (IL)-33 has been detected in intestinal samples of patients with ulcerative colitis, a condition associated with increased risk for colon cancer, but its role in the development of colorectal cancer has yet to be fully examined. Here, we investigated the role of epithelial expressed IL-33 during development of intestinal tumors. IL-33 expression was detected in epithelial cells in colorectal cancer specimens and in the Apc Min/+ mice. To better understand the role of epithelial-derived IL-33 in the intestinal tumorigenesis, we generated transgenic mice expressing IL-33 in intestinal epithelial cells (V33 mice). V33 Apc Min/+ mice, resulting from the cross of V33 with Apc Min/+ mice, had increased intestinal tumor burden compared with littermate Apc Min/+ mice. Consistently, Apc Min/+ mice deficient for IL-33 receptor (ST2), had reduced polyp burden. Mechanistically, overexpression of IL-33 promoted expansion of ST2+ regulatory T cells, increased Th2 cytokine milieu, and induced alternatively activated macrophages in the gut. IL-33 promoted marked changes in the expression of antimicrobial peptides, and antibiotic treatment of V33 Apc Min/+ mice abrogated the tumor promoting-effects of IL-33 in the colon. In conclusion, elevated IL-33 signaling increases tumor development in the Apc Min/+ mice.Zhengxiang HeLili ChenFabricio O. SoutoClaudia Canasto-ChibuqueGerold BongersMadhura DeshpandeNoam HarpazHuaibin M. KoKevin KelleyGlaucia C. FurtadoSergio A. LiraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Zhengxiang He
Lili Chen
Fabricio O. Souto
Claudia Canasto-Chibuque
Gerold Bongers
Madhura Deshpande
Noam Harpaz
Huaibin M. Ko
Kevin Kelley
Glaucia C. Furtado
Sergio A. Lira
Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice
description Abstract Increased expression of Interleukin (IL)-33 has been detected in intestinal samples of patients with ulcerative colitis, a condition associated with increased risk for colon cancer, but its role in the development of colorectal cancer has yet to be fully examined. Here, we investigated the role of epithelial expressed IL-33 during development of intestinal tumors. IL-33 expression was detected in epithelial cells in colorectal cancer specimens and in the Apc Min/+ mice. To better understand the role of epithelial-derived IL-33 in the intestinal tumorigenesis, we generated transgenic mice expressing IL-33 in intestinal epithelial cells (V33 mice). V33 Apc Min/+ mice, resulting from the cross of V33 with Apc Min/+ mice, had increased intestinal tumor burden compared with littermate Apc Min/+ mice. Consistently, Apc Min/+ mice deficient for IL-33 receptor (ST2), had reduced polyp burden. Mechanistically, overexpression of IL-33 promoted expansion of ST2+ regulatory T cells, increased Th2 cytokine milieu, and induced alternatively activated macrophages in the gut. IL-33 promoted marked changes in the expression of antimicrobial peptides, and antibiotic treatment of V33 Apc Min/+ mice abrogated the tumor promoting-effects of IL-33 in the colon. In conclusion, elevated IL-33 signaling increases tumor development in the Apc Min/+ mice.
format article
author Zhengxiang He
Lili Chen
Fabricio O. Souto
Claudia Canasto-Chibuque
Gerold Bongers
Madhura Deshpande
Noam Harpaz
Huaibin M. Ko
Kevin Kelley
Glaucia C. Furtado
Sergio A. Lira
author_facet Zhengxiang He
Lili Chen
Fabricio O. Souto
Claudia Canasto-Chibuque
Gerold Bongers
Madhura Deshpande
Noam Harpaz
Huaibin M. Ko
Kevin Kelley
Glaucia C. Furtado
Sergio A. Lira
author_sort Zhengxiang He
title Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice
title_short Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice
title_full Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice
title_fullStr Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice
title_full_unstemmed Epithelial-derived IL-33 promotes intestinal tumorigenesis in Apc Min/+ mice
title_sort epithelial-derived il-33 promotes intestinal tumorigenesis in apc min/+ mice
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/88385b01bc9042b29b43f9645a0ed849
work_keys_str_mv AT zhengxianghe epithelialderivedil33promotesintestinaltumorigenesisinapcminmice
AT lilichen epithelialderivedil33promotesintestinaltumorigenesisinapcminmice
AT fabricioosouto epithelialderivedil33promotesintestinaltumorigenesisinapcminmice
AT claudiacanastochibuque epithelialderivedil33promotesintestinaltumorigenesisinapcminmice
AT geroldbongers epithelialderivedil33promotesintestinaltumorigenesisinapcminmice
AT madhuradeshpande epithelialderivedil33promotesintestinaltumorigenesisinapcminmice
AT noamharpaz epithelialderivedil33promotesintestinaltumorigenesisinapcminmice
AT huaibinmko epithelialderivedil33promotesintestinaltumorigenesisinapcminmice
AT kevinkelley epithelialderivedil33promotesintestinaltumorigenesisinapcminmice
AT glauciacfurtado epithelialderivedil33promotesintestinaltumorigenesisinapcminmice
AT sergioalira epithelialderivedil33promotesintestinaltumorigenesisinapcminmice
_version_ 1718384912376004608